• br Introduction Glioblastoma GBM World Health Organization

  2020-07-30

  

  Introduction Glioblastoma (GBM; World Health Organization [WHO] grade IV gliomas) remains one of the most difficult-to treat-tumor types, as multiple genetic lesions promote therapy resistance, complemented by severe destructive infiltration of the surrounding NGB 2904 (Louis et al., 2016, Welle

• Abnormal patterns of DNA methylation in cancer cells

  2020-07-30

  

  Abnormal patterns of DNA methylation in cancer cells have been recognized for more than 20 years (Brown and Strathdee, 2002). A growing number of cancer genes are being recognized that harbor dense methylation in normally unmethylated promoter CpG islands (Baylin et al., 1998, Jones and Laird, 1999)

• Alternatively receptors may be customized to

  2020-07-30

  

  Alternatively, receptors may be customized to fulfill novel tasks, as has been demonstrated for the modular extracellular sensor architecture (MESA) receptors that enable Gallein to sense vascular endothelial growth factor (VEGF) and, in response, secrete IL-2 [94]. MESA receptors are composed of a

• Introduction Cysteinyl leukotrienes CysLTs LTC LTD and LTE

  2020-07-30

  

  Introduction Cysteinyl leukotrienes (CysLTs), LTC4, LTD4 and LTE4, are 5-lipoxygenase pathway metabolites of arachidonic herpes simplex virus 2 and deeply involved in bronchial asthma via activation of CysLT1 receptors [1], [2]. Specific CysLT1 receptor antagonists, including pranlukast [3], [4] an

• br Materials and methods br

  2020-07-30

  

  Materials and methods Results Discussion In the present study, as a trial to evaluate the marine ciliate E. crassus for further studies, its susceptibilities to B[a]P and β-NF were measured. Acute toxicity of B[a]P in aquatic organisms has been extensively studied, but not enough data is a

• br Significance Preclinical data indicate

  2020-07-30

  

  Significance Preclinical data indicate that tumor-associated macrophages (TAMs) represent an attractive therapeutic target as they represent key orchestrators of various tumor-promoting processes, such as escape of immune surveillance. Here, we report that treatment with an anti-CSF-1R antibody (

• br Conclusion Further optimization of a azaindole

  2020-07-30

  

  Conclusion Further optimization of a 7-azaindole-3-acetic atp gamma s chemotype derived from HTS delivered a new sub-series of selective CRTh2 receptor antagonists. Exploiting observations from the earlier sulfonamide sub-series, where lipophilicity reduction led to improved eosinophil SC potency

• Crm regulates these factors by interacting with their NES

  2020-07-30

  

  Crm1 regulates these factors by interacting with their NES and targeting them spatially and temporally to centrosomes. It is likely that Crm1 supplies a docking site for these factors at centrosomes and regulates their localization and function . But it is still unknown the mechanism for Crm1 to tar

• br Acknowledgements This work was supported by funding from

  2020-07-30

  

  Acknowledgements This work was supported by funding from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-06346 to JB), National Institute of Child Health and Human Development (5R01HD083930-02 to JB), and the National Institute of Biomedical Imaging and Bioengineering

• The acetylcholinesterasic activity of exposed animals

  2020-07-30

  

  The acetylcholinesterasic activity of exposed animals, after treatment with diverse concentrations of uranium and following distinct recovery periods, remained unaltered for all species. This finding suggests that uranium, in spite of being a water-soluble metal, does not exert any effect on the sel

• Given the importance of cysteine cathepsin inhibitors as

  2020-07-29

  

  Given the importance of cysteine cathepsin inhibitors as putative therapeutic molecules and microbial virulence factors, we chose to investigate whether Yersinia enterocolitica may be a potent producer of such inhibitors. Y. enterocolitica is the most heterogeneous species within the genus Yersinia.

• Albiglutide a glucagon like peptide agonist

  2020-07-29

  

  Albiglutide, a glucagon-like peptide-1 agonist (GLP-1 agonist) for the treatment of type 2 diabetes (marketed as Tanzeum and as Eperzan and the US and Europe, respectively), was one of the first HSA-peptide or protein fusion product to be approved for clinical use. Whereas the Fmoc-Ala-OMe australi

• Albiglutide a glucagon like peptide agonist

  2020-07-29

  

  Albiglutide, a glucagon-like peptide-1 agonist (GLP-1 agonist) for the treatment of type 2 diabetes (marketed as Tanzeum and as Eperzan and the US and Europe, respectively), was one of the first HSA-peptide or protein fusion product to be approved for clinical use. Whereas the ZD 9379 of pharmacolo

• KW 3902 Yang et al studied anti inflammatory and

  2020-07-29

  

  Yang et al. studied anti-inflammatory and antioxidant activities of methanol extract of the fruits of Foeniculum vulgare (F. vulgare) traditionally used to treat inflammatory diseases. Four coumarins viz scopoletin 13, 8-methoxypsoralen 14, bergapten 15 and imperatorin 16 were isolated. Although fou

• CE ribotyping applied on a Czech

  2020-07-29

  

  CE-ribotyping applied on a Czech C. difficile isolate collection demonstrates its high discrimination capability and the results highlight the need to use a standardised protocol as well as a standardised CE-ribotyping profile library to gain inter-laboratory comparable data on clinically and/or epi

15006 records 797/1001 page Previous Next First page 上5页 796797798799800 下5页 Last page